Commercial and scientific update
Subscribe to our investor alert service and receive all press releases, financial results and other key shareholder messages as soon as they become available.
Please enter your name and email address in the box below, select Subscribe and click Submit to add your name to our list. You will receive an email confirming your registration.
Aquis-listed ProBiotix Health taps into demand for cardiovascular disease treatments
Stephen O'Hara | 23 February 2023
IG UK | Youtube